PRDM15 antibody
Principal name
PRDM15 antibody
Alternative names for PRDM15 antibody
C21orf83, ZNF298, Zinc finger protein 298, PR domain zinc finger protein 15, PR domain-containing protein 15
SwissProt ID
P57071 (Human)
Gene ID
63977 (PRDM15)
Ncbi ID
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB)
Background of PRDM15 antibody
- Kit Component:
- - KN219769G1, PRDM15 gRNA vector 1 in pCas-Guide vector
- KN219769G2, PRDM15 gRNA vector 2 in pCas-Guide vector
- KN219769D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Shibuya,K., (2005) Biochem. Biophys. Res. Commun. 332 (2), 557-568
Immunofluorescence of purified MaxPab antibody to PRDM15 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of PRDM15 expression in transfected 293T cell line (H00063977-T01) by PRDM15 MaxPab polyclonal antibody.Lane 1: PRDM15 transfected lysate(125.51 KDa).Lane 2: Non-transfected lysate.
Human 293T; WB Suggested Anti-PRDM15 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: 293T cell lysate; PRDM15 antibody - middle region (ARP45785_P050) in Human 293T cells using Western Blot
Human 293T; WB Suggested Anti-PRDM15 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 293T cell lysate; PRDM15 antibody - C-terminal region (ARP36148_P050) in Human 293T cells using Western Blot
WB Suggested Anti-PRDM15 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 312500; Positive Control: 293T cell lysate
WB Suggested Anti-PRDM15 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: 293T cell lysate
Lysates
| Catalog No. | ||
|---|---|---|
| LY411787 | PRDM15 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC222567L2V | Lenti ORF particles, PRDM15 (mGFP-tagged)-Human PR domain containing 15 (PRDM15), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,680.00
|
|
| OriGene Technologies, Inc. | ||
| RC219769L2V | Lenti ORF particles, PRDM15 (mGFP-tagged)-Human PR domain containing 15 (PRDM15), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,470.00
|
|
| OriGene Technologies, Inc. | ||
| RC222567L1V | Lenti ORF particles, PRDM15 (Myc-DDK-tagged)-Human PR domain containing 15 (PRDM15), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,420.00
|
|
| OriGene Technologies, Inc. | ||
| RC219769L1V | Lenti ORF particles, PRDM15 (Myc-DDK-tagged)-Human PR domain containing 15 (PRDM15), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,230.00
|
|
| OriGene Technologies, Inc. | ||